BCA
CLVS

Berman Capital Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Berman Capital Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1K Buy
+256
New +$1.23K ﹤0.01% 2028
2019
Q3 		– Sell
-45
Closed – – 1626
2019
Q2 		$0 Hold
45
– – ﹤0.01% 1619
2019
Q1 		$1K Hold
45
– – ﹤0.01% 1297
2018
Q4 		$0 Buy
+45
New +$919 ﹤0.01% 1291

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Berman Capital Advisors's CLVS Position: Q3 2021 in Review

Berman Capital Advisors opened a new position in Clovis Oncology, Inc. (CLVS) in Q3 2021: 256 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2028 among its holdings. This is a return to the name: Berman Capital Advisors previously reported a position in CLVS as recently as Q2 2019.

Berman Capital Advisors first reported a position in CLVS in Q4 2018 and has held it in 4 quarters since. 157 funds tracked by Wall St. Rank hold CLVS as of Q3 2021.

  • Berman Capital Advisors held 256 shares of Clovis Oncology, Inc. worth $1K as of Q3 2021.
  • Clovis Oncology, Inc. was a new Berman Capital Advisors position in Q3 2021.
  • Clovis Oncology, Inc. made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #2028 holding.
  • Berman Capital Advisors first reported a position in Clovis Oncology, Inc. in Q4 2018 and has held it in 4 quarters since.
  • 157 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.